[1]
B. Zhang, X. Wang, and S. Ji, “PD-1/PD-L1 Antibody versus Gefitinib for Advanced Non-small Cell Lung Cancer: A Systematic Review and Network Meta-analysis of Randomized Control Trials”, J Integral Sci, vol. 2, no. 2, pp. 1-9, Jun. 2019.